An article outlining the effectiveness of GLP-1RAs on obesity
This can sometimes be temporary and may lessen as the body gets used to semaglutide
In a study done in 15 patients with PD, 200 mg of GSH was given intranasally and showed that GSH levels did not only raise, but the levels remained high even 1 hour after administration
We think this is a big deal. The company plans to seek regulatory approval for orforglipron for weight management by the end of this year and for the treatment of type 2 diabetes in 2026
18, 2025) Youve likely heard about glucagon-like peptide-1 agonists commonly referred to as GLP-1 medications, and more widely recognized through pharmaceutical brand names like Ozempic and Mounjaro
Paradoxically, a separate study published in the same journal, around the same time, analyzed body-contouring outcomes in GLP-1 patients, and did not find an increased rate of post-op complications